Výsledky vyhledávání - "Hubert Kuebler"

Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals

Autor: Mario W. Kramer, Julian P. Struck, Hubert Kuebler, Marie C. Hupe, Tomasz Ozimek, Boris Hadaschik, Marco J. Schnabel, Immanuel A Oppolzer, Maximilian Burger, Viktor Gruenwald, Maximilian Weinke, Christian Gratzke, Markus Grabbert, Alexander Katalinic, Maike Schnoor, Andrea Schulze, Jonas C Klockenbusch, Christopher Darr, Axel S. Merseburger

Publikováno v: World Journal of Urology

PurposeTo date, over 4.2 million Germans and over 235 million people worldwide have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Uro-oncology (UO) patients are particularly vulnerable but in urgent need of life-sav

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9552beb612b2ec0c50998ab41a3751
http://europepmc.org/articles/PMC8631559

Zobrazit plný text záznamu

Indications and Oncologic Outcome of Radical Cystectomy for Urothelial Bladder Cancer†

Autor: Margitta Retz, Juergen E. Gschwend, Hubert Kuebler, Michael Autenrieth

Publikováno v: European Urology Supplements. 9:10-18

Context Radical cystectomy (RC) offers the best opportunity for ultimate cure of high-grade and high-risk invasive bladder cancer (BCa). Objective To review the available literature on indications for and oncologic outcomes of RC for urothelial carci

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::118951ec6a674f05222c51630aea60ef
https://doi.org/10.1016/j.eursup.2010.01.004

Zobrazit plný text záznamu

A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part

Autor: Henoch S. Hong, Axel Heidenreich, Thomas van Erps, Andreas Schroeder, Mariola Fotin-Mleczek, Susan Feyerabend, Hubert Kuebler, Birgit Scheel, Valérie Reus, Margitta Retz, Karl-Josef Kallen, Ulrike Gnad-Vogt, Arnulf Stenzl, Sven D. Koch

Publikováno v: Journal for Immunotherapy of Cancer

Meeting abstracts CV9104 is a novel mRNA-based therapeutic vaccine for prostate cancer encoding the prostate cancer-associated antigens PSA, PSMA, PSCA, STEAP, PAP and MUC1 by engineered mRNA molecules optimized for protein expression and immunostimu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dc59bd81452db0003cae3d147432b3d
http://europepmc.org/articles/PMC4288759

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání